Question

Atomoxetine has been selected as the primary pharmacologic treatment for a young adult diagnosed with attention deficit hyperactivity disorder (ADHD). What characteristic makes this a good drug of choice for this population of clients? Select all that apply.

Answer 1

Answer below

Step-by-step explanation:

Atomoxetine is a non-stimulant medication approved by the FDA, it is often used to treat attention deficit hyperactivity disorder (ADHD).

It is a norepinephrine reuptake inhibitor, and has been shown to enhance the inhibitory mechanisms involved in the control of impulsive behaviors, it is easily absorbed after oral administration, being little affected by meals and is rapidly removed from the body through urine (3 to 5 hs). Because atomoxetine does not cause addiction, it is not classified as a controlled substance

(More info on noradrenaline inhibitors) - Inhibitors of noradrenaline reuptake (or norepinephrine) are antidepressant drugs that elevate extracellular neurotransmitter noradrenaline level, also called norepinephrine in the central nervous system. They act by preventing the reuptake of the neurotransmitter by preventing it from returning to the cellular interior of the pre-synaptic neuronal termination and remaining in the synaptic space. Medications that inhibit this class of neurotransmitter transporters are known as norepinephrine transporters.